The incidences of cerebral hemorrhage (CH), cerebral infarction (CI) and subarachnoid hemorrhage (SAH) were examined retrospectively in patients with chronic renal failure on maintenance hemodialysis, followed for 13 years in our 26 satellite dialysis centers. During 10,364 patient-years of experience (PYE), CH developed in 66, CI in 16, SAH in 3 and unclassified stroke in 5 cases. The incidence was 637 per 105 PYE for CH and 154 for CI, the former being approximately 5 times and the latter one third of the incidence of CH or CI in the general population in Japan.
The Chi-square test was also used for statistical analysis. P values less than 5% were considered to be significant.
RESULTS
Among 10,364 PYE, there were 90 cases of strokes (66 with CH, 16 with CI, 3 with SAH and 5 with CVD). Patient profiles of these cases are listed in Table I . CH comprised 73% of all the strokes and CI comprised 18%. The average age of the patients did not differ between CH(53 yrs) and CI (59 yrs), but it was significantly higher in CH(p<0.05) and CI(p<0.01) than in SAH(38 yrs). The duration of hemodialysis treatment prior to strokes ranged from 18 to 61 months, but the differences were not statistically significant among the groups of patients.
Fifty-five of 66 CH cases and 8 of 16 CI cases died from the stroke, and all 3 SAH and 4 of 5 CVD cases were fatal as well.
The incidence of strokes per 105 PYE is shown in Table II . The incidence of CH was 637 per 105 PYE, being 4 times greater than the incidence of CI (154). By contrast, the incidence of SAH was very low (29).
The time interval from the end of the last hemodialysis session to the 100% within 1 month of hemorrhage.
By contrast, 13% of the CI patients died within 24 hours, 26% within 3 days and 76% within 1 month. This difference in survival time between CH and CI patients was significant by a Chi-square test (p<0.01), indicating that CH patient died much earlier than CI patients.
DISCUSSION
The incidence of strokes has not yet been reported in a large number of maintenance hemodialysis patients. However the present results can be compared with the data obtained by field surveys in epidemiological studies. Robins and Baum,6) who summarized previous reports in the literature, stated that the incidence of CH in the U.S.A. and Europe ranged between 17 to 88 per 105 PYE. On the other hand, in the Japanese general population, the incidence has been reported to be 1207) or 2128) per 105 PYE in the 1970s. Thus, the incidence of CH in hemodialysis patients was 3 to 5 times higher than the incidence in the general population, indicating that this class of patients is at greater risk.
Possible causative factors for intracranial hemorrhages in these patients include hypertension, systemic heparinization, ultrafiltration to treat fluid accumulation, poor platelet adhesion and vascular access infection9),10); the potential roles of hypertension and anticoagulant have been especially emphasized. According to our previous report, 58% of maintenance hemodialysis patients were hypertensive,11) while the present study found that 66.7% of hemodialysis patients with CH had hypertension.
Recent advances in the treatment of hypertension may decrease the death rate from stroke in the first 6 months of dialysis into a tenth of the figure in the mid-1960s .9) However, a majority of the hemodialysis patients still have hypertension , which may be partly responsible for a higher incidence of CH in hemodialysis patients.
In regular hemodialysis a high dose of heparin is given 3 times a week Jpn. Heart J. S eptember 1986 4 to 5 hours each during hemodialysis. The anticoagulant effects of heparin persist for 6 hours after administration.
Siddiqui et al4) have reported a prolonged clotting time as a causative factor of death in 3 out of 4 cases of intracranial hemorrhage.
Even in the absence of hemodialysis, 31 % of the sudden deaths from CH were found to be on long-term oral anticoagulant therapy.12) However, the shorter survival time suggests that CH in hemodialysis patients is clinically more severe. In fact, CT scans from this group of patients demonstrated large hematoma in the cerebral hemispheres or in the brain stem.13) Systemic heparinization seems to be an important factor in the poor prognosis of these patients. According to epidemiological studies in Japan, the incidence of CI was 4707) or 5868) per 105 PYE, whereas it was 154 per 105 PYE in hemodialysis patients.
Thus, there is a major difference in the incidence of CH and CI in hemodialysis patients and the general population, with a higher incidence of CH and a lower incidence of CI in these patients.
It is suggested that heparinization, rather than hypertension plays a more important role in either the development of CH or the prevention of CI in the hemodialysis patients. In the present study, all cases of SAH died but the small sample size precludes f urther analysis of the data. Thus, further studies of this less common group of patients are needed to determine possible risk factors for SAH as a function of hemodialysis.
